恆大地產兩隻債券將召開持有人會議 擬申請付息及回售兌付展期一年
恆大地產集團公布,將於周四至周五(3至4日)召開2019年公開發行公司債券「19恆大01」及「19恆大02」本年第二次債券持有人會議,擬申請將「19恆大01」於2021年5月6日至2022年5月5日期間的利息支付時間,調整至2023年5月6日完成支付,即展期一年;申請將「19恆大02」回售部分債券兌付日調整為2023年5月6日,即展期一年。
「19恆大01」發行規模150億元人民幣(下同),票面利率6.27厘,債券期限為4年期,附第二年末發行人調整票面利率選擇權及投資者回售選擇權。「19恆大02」發行規模50億元,票面利率6.8厘,債券期限為5年期,附第三年末發行人調整票面利率選擇權及投資者回售選擇權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.